Biogen Inc (NASDAQ:BIIB)
| 383.52 Delayed Data As of Jun 17 |  -7.79 / -1.99%Today’s Change | 223.25 Today|||52-Week Range 468.55 | +56.63% Year-to-Date |
Latest BIIB News | Press Releases
Today’s Trading
| Previous close | 391.31 |
| Today’s open | 391.31 |
| Day’s range | 380.17 - 396.89 |
| Volume | 1,832,967 |
| Average volume (3 months) | 1,591,743 |
| Market cap | $59.7B |
Data as of 4:00pm ET, 06/17/2021
Growth & Valuation
| Earnings growth (last year) | -21.00% |
| Earnings growth (this year) | -45.20% |
| Earnings growth (next 5 years) | -2.85% |
| Revenue growth (last year) | -2.82% |
| P/E ratio | 19.8 |
| Price/Sales | 3.20 |
| Price/Book | 5.65 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | +9.94 | +2.23% |
| ---- | ||
| MRNAModerna Inc | +4.63 | +2.34% |
| EXASExact Sciences Corp | +6.52 | +5.42% |
Data as of 3:59pm ET, 06/17/2021
Financials
| Next reporting date | July 27, 2021 |
| EPS forecast (this quarter) | $4.61 |
| Annual revenue (last year) | $12.4B |
| Annual profit (last year) | $4.0B |
| Net profit margin | 32.38% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
